Digital Health
Venture capital panelists discussed how the collapse of Silicon Valley Bank earlier this month could affect digital health at ViVE 2023.
The company targets to receive a similar clearance from the US FDA by yearend.
Panelists at ViVE 2023 discussed the future of preventive medicine as retail chains and virtual care players push into the space and more patients avoid primary care altogether.
The online pharmacy is partnering with GSK, Kaléo, Novo Nordisk and Dexcom to include coupons for their brand-name medications.
It has been approved for use in both clinical and home settings.
The company will use the funds to continue its growth in the U.S.
During a discussion at ViVE 2023, panelists discussed how technology could make it easier for patients to access healthcare.
The company has let go of approximately 35% of its workforce.
The latest cohort includes 23 companies focused on technology for retaining, deploying and training healthcare workers.
Dr. Maulik Majmudar, chief medical officer and cofounder of Biofourmis, discusses why healthcare often struggles to address the consumer experience.